molecules-logo

Journal Browser

Journal Browser

Kinases in Signal Transduction

A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Chemical Biology".

Deadline for manuscript submissions: closed (1 May 2021) | Viewed by 294

Special Issue Editor


E-Mail Website
Guest Editor
Translational Genomics Research Institute, Phoenix, AZ, USA
Interests: biological Mass Spectrometry; proteomics; phosphoproteomics; targeted proteomics; metaproteomics; microbial proteomics; cancer biology; kinases; signal transduction; PTMs; neurological disorders
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The kinases are a small yet diverse family of proteins that regulate most of the signal transduction pathways in a cell. In turn, post-translational modifications such as phosphorylation and ubiquitination regulate kinase activity by altering their structure, their sub-cellular localization, or their interactions with other proteins. Mutations in kinases are the known drivers for several human malignancies, and therefore many FDA-approved targeted therapies are directed towards kinases. However, as kinases exhibit a high degree of structural similarity, their inhibitors are notoriously promiscuous, and researchers are striving to develop potent kinase inhibitors with high specificity. Understanding how the kinases recognize their substrates is another interesting field of research that is driven by developments in phosphoproteomics, chemical proteomics, kinome profiling, array-based technologies, and bioinformatics.

With this Special Issue, the aim is to highlight the cutting-edge research shaping our understanding of kinases and their role in signaling pathways. The present Special Issue welcomes studies ranging from the global profiling of kinases using different analytical methods and omics approaches to studies shedding light onto the role played by individual kinases using traditional molecular and cell biology methods. This is also a call to researchers who are using computational chemistry and bioinformatics to understand kinase sequences and structures, substrate recognition by kinases, and developing small-molecule kinase inhibitors.

Dr. Ritin Sharma
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • Kinases
  • kinase-substrate analysis
  • cell signaling
  • kinome profiling
  • computer-aided drug design
  • kinase inhibitors
  • activity-based kinase profiling
  • post-translational modifications
  • proteomics
  • phosphoproteomics

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop